The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies (Q27704823)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies	scientific article

Statements

scholarly article

0 references

The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies (English)

0 references

0 references

Giuseppina De Simone

2

0 references

1

0 references

Claudiu T Supuran

7

0 references

Vincenzo Alterio

3

0 references

Jean-Yves Winum

5

0 references

object named as

Fabrizio Carta

6

0 references

author name string

Vincenzo Riccio

4

0 references

publication date

7 June 2016

0 references

Organic and Biomolecular Chemistry

0 references

14

0 references

21

0 references

4853-8

0 references

Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Antiepileptic activity of zonisamide on hippocampal CA3 neurons does not depend on carbonic anhydrase inhibition

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Structure-based drug discovery of carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I-topiramate complex

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Acetazolamide for the treatment of idiopathic intracranial hypertension

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

How many carbonic anhydrase inhibition mechanisms exist?

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Searching for intermediates in Prins cyclisations: the 2-oxa-5-adamantyl carbocation

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

(In)organic anions as carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Inhibition of mammalian carbonic anhydrases I-XIV with grayanotoxin III: solution and in silico studies.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII.

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Refined structure of human carbonic anhydrase II at 2.0 A resolution

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases fromMycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1039%2FC6OB00803H

21 January 2018

Identifiers

10.1039/C6OB00803H

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27704823&oldid=984754867"